L. Chauvenet

798 total citations
17 papers, 514 citations indexed

About

L. Chauvenet is a scholar working on Oncology, Surgery and Reproductive Medicine. According to data from OpenAlex, L. Chauvenet has authored 17 papers receiving a total of 514 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 7 papers in Surgery and 4 papers in Reproductive Medicine. Recurrent topics in L. Chauvenet's work include Intraperitoneal and Appendiceal Malignancies (5 papers), Intestinal and Peritoneal Adhesions (5 papers) and Ovarian cancer diagnosis and treatment (4 papers). L. Chauvenet is often cited by papers focused on Intraperitoneal and Appendiceal Malignancies (5 papers), Intestinal and Peritoneal Adhesions (5 papers) and Ovarian cancer diagnosis and treatment (4 papers). L. Chauvenet collaborates with scholars based in France, Austria and United Kingdom. L. Chauvenet's co-authors include A. Cull, Ann‐Charlotte Waldenström, Juan Ignacio Arrarás, Elfriede Greimel, Sven D’haese, Bernhard Holzner, Andrew Bottomley, Karin Kuljanić, Jérémie Lebrec and Pascale Mariani and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and British Journal of Cancer.

In The Last Decade

L. Chauvenet

17 papers receiving 504 citations

Peers

Countries citing papers authored by L. Chauvenet

Since Specialization

Citations

This map shows the geographic impact of L. Chauvenet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L. Chauvenet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L. Chauvenet more than expected).

Fields of papers citing papers by L. Chauvenet

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L. Chauvenet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L. Chauvenet. The network helps show where L. Chauvenet may publish in the future.

Co-authorship network of co-authors of L. Chauvenet

This figure shows the co-authorship network connecting the top 25 collaborators of L. Chauvenet. A scholar is included among the top collaborators of L. Chauvenet based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L. Chauvenet. L. Chauvenet is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

#	Work	Indexed citations
1	Quality of life and impact of pain in women treated with aromatase inhibitors for breast cancer. A multicenter cohort study 2017 ·PLoS ONE ·F. Laroche, Serge Perrot, (unknown), Paul Cottu, Jean‐Yves Pierga, Jean‐Pierre Lotz, K. Beerblock, Christophe Tournigand, L. Chauvenet, Didier Bouhassira, Joël Coste	35
2	Sustained response to vemurafenib in a low grade serous ovarian cancer with a BRAF V600E mutation 2015 ·Investigational New Drugs ·Pierre Combe, L. Chauvenet, Marie‐Aude Lefrère‐Belda, Hélène Blons, (unknown), Stéphane Oudard, Éric Pujade-Lauraine	23
3	Recommendations for Bowel Obstruction With Peritoneal Carcinomatosis 2014 ·Journal of Pain and Symptom Management ·(unknown), (unknown), Frédéric Guirimand, L. Chauvenet, (unknown), Aurélie Durand, Éric François, Martine Gabolde, Pascale Mariani, Christine Rebischung, Vincent Servois, Éric Terrebonne, C. Arvieux	77
4	A clinical experience of single agent bevacizumab in relapsing ovarian cancer 2013 ·Gynecologic Oncology ·George Emile, L. Chauvenet, Jean‐Marie Tigaud, Jean Chidiac, Eric Pujade Lauraine, Jérôme Alexandre	17
5	Symptomatic Treatment With Lanreotide Microparticles in Inoperable Bowel Obstruction Resulting From Peritoneal Carcinomatosis 2013 ·Obstetrical & Gynecological Survey ·Pascale Mariani, Joëlle Blumberg, Alain Landau, (unknown), Estelle Botton, Olivier Béatrix, Didier Mayeur, (unknown), Pascal Maisonobe, L. Chauvenet	2
6	Symptomatic Treatment With Lanreotide Microparticles in Inoperable Bowel Obstruction Resulting From Peritoneal Carcinomatosis: A Randomized, Double-Blind, Placebo-Controlled Phase III Study 2012 ·Journal of Clinical Oncology ·Pascale Mariani, Joëlle Blumberg, Alain Landau, (unknown), Estelle Botton, Olivier Béatrix, Didier Mayeur, (unknown), Pascal Maisonobe, L. Chauvenet	37
7	Traitement symptomatique de l'occlusion intestinale sur carcinose péritonéale : Recommandations de bonnes pratiques cliniques 2012 ·Médecine Palliative ·(unknown), (unknown), (unknown), C. Arvieux, L. Chauvenet, (unknown), Aurélie Durand, Éric François, Martine Gabolde, Frédéric Guirimand, (unknown), (unknown), (unknown), Pascale Mariani, Christine Rebischung, Vincent Servois, Éric Terrebonne	3
8	Can we predict chemo-induced hematotoxicity in elderly patients treated with pegylated liposomal doxorubicin? Results of a population-based model derived from the DOGMES phase II trial of the GINECO 2012 ·Journal of Geriatric Oncology ·Alexandre Sostelly, Émilie Hénin, L. Chauvenet, Anne‐Claire Hardy‐Bessard, (unknown), (unknown), Cécile Leyronnas, Catherine Ligeza‐Poisson, (unknown), (unknown), (unknown), Jean-Michel Vannetzel, Gilles Freyer, Michel Tod, Claire Falandry	10
9	Efficacy of lanreotide 30 mg as symptomatic treatment in patients with inoperable bowel obstruction due to peritoneal carcinomatosis: A randomized double-blind, placebo-controlled study. 2011 ·Journal of Clinical Oncology ·Pascale Mariani, Joëlle Blumberg, L. Chauvenet	1
10	Docetaxel (Do) and gemcitabine (Gem) in advanced pancreatic cancer (APC) patients (pts): A multicentre study 2007 ·Journal of Clinical Oncology ·G. Des Guetz, L. Chauvenet, D. Paraïso, Didier Mayeur, Thomas Aparicio, (unknown), (unknown), (unknown), Eric Pujade Lauraine	1
11	Phase II study of gemcitabine in combination with docetaxel in patients with advanced pancreatic carcinoma. Preliminary results 2005 ·Journal of Clinical Oncology ·L. Chauvenet, G. Des Guetz, Thomas Aparicio, (unknown), (unknown), (unknown), Didier Mayeur, (unknown), Carole Bouleuc, D. Paraïso, Éric Pujade-Lauraine	2
12	Lack of relationship between EGFR-1 immunohistochemical expression and prognosis in a multicentre clinical trial of 93 patients with advanced primary ovarian epithelial cancer (GINECO group) 2004 ·British Journal of Cancer ·C. Elie, J.-F. Geay, Michael Morcos, A. Le Tourneau, V. Girre, Philippe Broët, B Marmey, L. Chauvenet, Josée Audouin, Éric Pujade-Lauraine, Sophie Camilleri‐Broët	42
13	An international field study of the reliability and validity of a disease-specific questionnaire module (the QLQ-OV28) in assessing the quality of life of patients with ovarian cancer 2003 ·European Journal of Cancer ·Elfriede Greimel, Andrew Bottomley, A. Cull, Ann‐Charlotte Waldenström, Juan Ignacio Arrarás, L. Chauvenet, Bernhard Holzner, Karin Kuljanić, Jérémie Lebrec, Sven D’haese	167
14	Development of a European Organization for Research and Treatment of Cancer questionnaire module to assess the quality of life of ovarian cancer patients in clinical trials 2001 ·European Journal of Cancer ·A. Cull, (unknown), Elfriede Greimel, Ann‐Charlotte Waldenström, Juan Ignacio Arrarás, Andrzej P. Kudelka, L. Chauvenet, A. Lawrence Gould	74
15	Accidents hémorragiques graves lors d'un traitement par héparine de bas poids moléculaire. À propos de deux observations 1997 ·La Revue de Médecine Interne ·Gilles Grateau, L. Chauvenet, Stéphane Oudard, C Bachmeyer, L Capron, MH Horellou, (unknown)	5
16	Haemoperitoneum due to necrosis of bulky retroperitoneal metastases: an unusual complication of chemotherapy for testicular cancer 1996 ·British Journal of Urology ·(unknown), Éric Pujade-Lauraine, Bertrand Guillonneau, L. Chauvenet, A Bernadou	7
17	Peripheral-T-Cell Lymphoma with Hemophagocytic Histiocytosis Localised to the Bone Marrow Associated with Inappropriate Secretion of Antidiuretic Hormone 1995 ·Leukemia & lymphoma ·(unknown), L. Chauvenet, Josée Audouin, Jérôme Rossert, (unknown), Marie‐Hélène Horellou, A Bernadou, Michel Samama	11

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact